Literature DB >> 9690518

Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells.

E B Carson-Walter1, D P Smith, B A Ponder, S B Baylin, B D Nelkin.   

Abstract

Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor of the calcitonin secreting thyroid C-cells. Somatic and germline mutations in the RET proto-oncogene are associated with sporadic and inherited cases of MTC, respectively. The human MTC cell line, TT, can be differentiated by activated raf-1. This differentiation is characterized, in part, by down-regulation of the RET proto-oncogene. We now show that raf-1 induction is followed by activation of the downstream kinases MEK1/2 and ERK1/2 and that differentiation is dependent on activation of MEK1/2. The concurrent down-regulation of RET appears to involve altered nuclear compartmentalization and transport of RET mRNA. Although RET is down-regulated during raf-1 mediated differentiation, overexpression of activated RET alleles which resist down-regulation does not alter the raf-1 mediated differentiation response. These data suggest that RET down-regulation is associated with, but not required, for raf-1 mediated MTC cell differentiation and that the raf-1 signal transduction pathway plays a dominant role in promoting MTC cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690518     DOI: 10.1038/sj.onc.1201938

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

2.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02

3.  Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.

Authors:  Seung-Keun Hong; Seunghee Yoon; Cas Moelling; Dumrongkiet Arthan; Jong-In Park
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

4.  The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.

Authors:  Jong-In Park; Christopher J Strock; Douglas W Ball; Barry D Nelkin
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

5.  Ancient origin of the new developmental superfamily DANGER.

Authors:  Nikolas Nikolaidis; Dimitra Chalkia; D Neil Watkins; Roxanne K Barrow; Solomon H Snyder; Damian B van Rossum; Randen L Patterson
Journal:  PLoS One       Date:  2007-02-14       Impact factor: 3.240

6.  Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.

Authors:  Muthusamy Kunnimalaiyaan; Megan R Haymart; Herbert Chen
Journal:  Transl Oncogenomics       Date:  2007-05-03

7.  The Role of STAT3 in Thyroid Cancer.

Authors:  Nadiya Sosonkina; Dmytro Starenki; Jong-In Park
Journal:  Cancers (Basel)       Date:  2014-03-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.